Skip to content

Group Therapy for Caregivers of Alzheimer's Disease Patients in Spanish Elderly Persons Centres

Group Therapy for Caregivers of Alzheimer's Disease Patients in Spanish Elderly Persons Centres

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02418806
Acronym
cuiDem
Enrollment
231
Registered
2015-04-16
Start date
2014-01-31
Completion date
2015-09-30
Last updated
2016-01-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer's Disease

Keywords

Family Caregivers, Psychotherapy Group

Brief summary

An experimental study designed to test the effectiveness of a psychological intervention based on group therapy for the caregivers of Alzheimer's disease patients. The intervention consists of 16 sessions of a cognitive-behavioral psychological group therapy. This study aims to demonstrate that Alzheimer's patients' caregivers can decrease the feelings of burden after been involved in a group therapy.

Interventions

BEHAVIORALPsychotherapy groups
BEHAVIORALSelf-help groups

Sponsors

Barcelonabeta Brain Research Center, Pasqual Maragall Foundation
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Main caregiver of an Alzheimer Disease Patient. * Alzheimer Disease Patient with mild/severe cognitive impairment. * High compliance to therapy sessions. * Sign informed consent.

Exclusion criteria

* Low commitment to develop all study phases. * Caregiver activity remunerated. * Caregiver with psychiatric disorders that can affect the development of the sessions. * Caregivers who have received psychological care during last year.

Design outcomes

Primary

MeasureTime frame
Efficacy of group therapy in caregiver burden measured by Zarit Burden Interview.16 months

Secondary

MeasureTime frame
Change in anxiety and depression from baseline compared to the control and active arms measured by Goldberg Scale.4 months and 16 months
Descriptive analysis of the caregivers' characteristics (sociodemographics, relation wih the AD patient).Baseline (0 months)
Descriptive analysis of the caregiver's cognition using DEM-DETECT Module 1.4 months
Change in caregiver burden from baseline compared to the control and active arms measured by Zarit Burden Interview.4 months and 16 months
Change in quality of life from baseline compared to the control and active arms measured by Casp-19 and SF-36 questionnaires.4 months - 16 months
Change in resilience from baseline compared to the control and active arms measured by Connor-Davidson Resilience Scale.4 months - 16 months
Change in functional social support from baseline compared to the control and active arms using Duke-UNC questionnaire.4 months - 16 months
Preliminary cost-effectiveness analysis related resources needed to caregivers and Alzheimer patients.4 months - 16 months

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026